XML 53 R39.htm IDEA: XBRL DOCUMENT v3.25.3
Financial Instruments and Fair Value Measurements (Tables)
12 Months Ended
Sep. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Cash and Cash Equivalents
The following reconciles cash and equivalents and restricted cash reported within the Company's consolidated balance sheets at September 30, 2025 and 2024 to the total of these amounts shown on the Company's consolidated statements of cash flows:
(Millions of dollars)20252024
Cash and equivalents$641 $1,717 
Restricted cash210 139 
Cash and equivalents and restricted cash$851 $1,856 
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The fair values of the Company’s financial instruments are as follows:
(Millions of dollars)Basis of fair value measurement (See Note 1)20252024
Institutional money market accounts (a)Level 1$18 $285 
Current portion of long-term debt (b)Level 2700 1,748 
Long-term debt (b)Level 216,745 17,199 
(a)These financial instruments are recorded within Cash and equivalents on the consolidated balance sheets. The institutional money market accounts permit daily redemption.
(b)Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.
Transfer of Financial Assets Accounted for as Sales The amounts transferred and yet to be remitted under factoring arrangements are provided below.
(Millions of dollars)202520242023
Trade receivables transferred to third parties under factoring arrangements$1,560 $1,385 $2,615 
(Millions of dollars)20252024
Amounts yet to be collected and remitted to the third parties$389 $254 
Supplier Finance Program A rollforward of the Company’s outstanding obligations under its supplier finance programs is provided below.
(Millions of dollars)
Balance at September 30, 2024
$112 
Additions807 
Settlements(686)
Balance at September 30, 2025
$234